Treatment methods for extravasations of chemotherapeutic agents: a comparative study

Area of Science:

• Oncology
• Surgical Pathology
• Pharmacology

Background:

• Vesicant chemotherapy agents can cause severe cutaneous ulcers upon extravasation.
• Current antidote treatments for extravasation injuries have shown variable effectiveness.
• Preventing and managing these ulcers is crucial for patient outcomes.

Purpose of the Study:

• To compare the efficacy of early surgical debridement versus injectable and topical antidotes in preventing chemotherapy-induced cutaneous ulcers.
• To evaluate the effectiveness of various interventions in limiting ulcer size and promoting healing after vesicant extravasation.

Main Methods:

• A rat model was utilized to simulate extravasation injuries from doxorubicin, vincristine, actinomycin D, mitomycin C, and carmustine (BCNU).
• Animals received debridement at varying intervals post-injection or immediate application of selected antidotes.
• Ulcer size and healing rates were assessed for each intervention.

Main Results:

• Many commonly used "antidotes" were ineffective in limiting ulcer size or promoting rapid healing.
• Early surgical debridement demonstrated the greatest effectiveness in reducing ulcer size.
• Surgical debridement significantly facilitated faster ulcer healing compared to other methods tested.

Conclusions:

• Early surgical debridement is the most effective intervention for managing vesicant chemotherapy extravasation injuries.
• Topical and injectable antidotes commonly used were largely ineffective in this experimental model.
• Prompt surgical intervention should be considered for severe extravasation events.